The Prevalence of CTX Disorder in Juvenile Cataract Cases in Turkey

• Conditions: Cerebrotendinous Xanthomatosis

• Registration Number: NCT03584893
• Lead Sponsor: TRPHARM

Brief Summary

Epidemiologic observational study. Study will include two phases:

1. Retrospective cross-sectional phase: At this stage of the study, retrospective screenings are carried out at study sites and all juvenile cataract cases are planned to be determined.

2. Prospective phase: At this stage of the study, identified juvenile cataract cases as a result of retrospective screenings will be called to be invited to the sites and blood samples will be obtained for the cholestanol tests for the cases that have given Informed Consent.

This observational study is designed in two phases; retrospective and prospective. Retrospective part includes screening the patient database and / or patient files at ophthalmology clinics participating in the study and identifying patients diagnosed with idiopathic juvenile cataracts. The data of patients with idiopathic juvenile cataracts will be reviewed and the data of the patients meeting the inclusion/exclusion criteria will be recorded. Once this phase is completed, the prospective phase of the study will start and the patients meeting the criteria will be invited to the site to participate in the study. Current data will be collected from the patients who agree to participate in the study and the clinical status of the patients will be evaluated according to the Mignarri index. In addition, blood will be obtained from all patients to diagnose CTX disease. Blood samples will be sent to Duzen Laboratories in Ankara and analyzed for cholestanol.

Detailed Description

Not available

Study Timeline

• Study Start: 2018-06-01
• Study First Submitted: 2018-06-19
• Study First Submitted QC: 2018-07-11
• Study First Posted: 2018-07-12
• Status Verified: 2021-03
• Last Update Submitted: 2021-03-25
• Last Update Posted: 2021-03-29
• Primary Completion: 2022-12-31
• Study Completion: 2023-03-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

• Providing the written informed consent form
• The patient should be diagnosed with idiopathic bilateral juvenile cataract
• Idiopathic bilateral juvenile cataract should be diagnosed while the patient must be take a day from one year (age)
• Syria ciziten who take their citizenship of Turkey could be enrolled to the study after signing of Informed Consent Form that translated to mother tongue by sworn translation office approved by ethic committee.

Exclusion Criteria

• If the patient has been diagnosed with CTX before his/her enrollment in the study,
• If the patient has been diagnosed with cataract due to any known reasons other than CTX including cataracts related to trauma,
• If the patient has been diagnosed with cataract due to cataractogenic treatments,
• If the patient has participated in an interventional clinical study within the last 30 days,
• If the patient and/or his/her legal representative does not provide consent to participate in the study,
• If the patient will not be able to fulfill study requirements according to the investigator's opinion,
• If the patient had used cholic acid or chenodeoxycholic acid on or before the date of participation in the study
• Pregnancy and/or lactation
• Syria citizen that have not Turkey citizenship will not enroll to the study.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Rate of juvenile cataract patients	"through study completion, an average of 3 years"	Rate of juvenile cataract patients whose cholestanol test result is above threshold (3.75 mg/mL) and suspected CTX cases

Secondary Outcome Measures

Name	Time	Method
Presence of consanguineous marriage	"through study completion, an average of 3 years"	Presence of consanguineous marriage
The frequency of the systemic findings	"through study completion, an average of 3 years"	The frequency of the following systemic findings: * Tendon xanthomas; * Chronic diarrhea; * Prolonged neonatal jaundice; * Early osteoporosis
The frequency of the neurological symptoms	"through study completion, an average of 3 years"	The frequency of the following neurological symptoms: * Cerebellar ataxia; * Spastic paraparesis; * Disruption of dentate nucleus signal detected by MRI; * Intellectual disability; * Psychiatric disorders; * Epilepsy; * Parkinson; * Polyneuropathy
CTX history in family	"through study completion, an average of 3 years"	The history of the disease will be assessed from the patient records and by interview

Trial Locations

Locations (36)

Adana Başkent University School of Medicine; 🇹🇷 Adana, Turkey

Adana State Hospital; 🇹🇷 Adana, Turkey

Çukurova University Medical Faculty Department of Ophtalmology; 🇹🇷 Adana, Turkey

Ankara Training and Research Hospital; 🇹🇷 Ankara, Turkey

Ankara University Medical Faculty Department of Ophtalmology; 🇹🇷 Ankara, Turkey

Başkent University School of Medicine; 🇹🇷 Ankara, Turkey

Dünya Göz Hospital; 🇹🇷 Ankara, Turkey

Hacettepe University Medical Faculty Department of Ophtalmology; 🇹🇷 Ankara, Turkey

Health Sciences University Ankara State Hospital; 🇹🇷 Ankara, Turkey

SBU Gülhane Training and Research Hospital; 🇹🇷 Ankara, Turkey

Scroll for more (26 remaining)